Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in J Interferon Cytokine Res

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    July 2018
  1. COOKSLEY H, Riva A, Katzarov K, Hadzhiolova-Lebeau T, et al
    Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2018;38:273-282.
    PubMed     Text format     Abstract available


    June 2018
  2. NAZ Z, Wahid B, Usman S, Saleem K, et al
    Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.
    J Interferon Cytokine Res. 2018;38:255-260.
    PubMed     Text format     Abstract available


    May 2018
  3. CAO WH, Li MH, Pan CQ, Lu Y, et al
    Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy.
    J Interferon Cytokine Res. 2018;38:197-205.
    PubMed     Text format     Abstract available


    March 2018
  4. EL-RAZIKY M, Khairy M, Fouad A, Salama A, et al
    Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.
    J Interferon Cytokine Res. 2018;38:129-136.
    PubMed     Text format     Abstract available


  5. WAHID B, Rafique S, Saleem K, Ali A, et al
    An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load.
    J Interferon Cytokine Res. 2018;38:122-128.
    PubMed     Text format     Abstract available


    February 2018
  6. ZAREBSKA-MICHALUK D, Flisiak R, Jaroszewicz J, Janczewska E, et al
    Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
    J Interferon Cytokine Res. 2018;38:93-100.
    PubMed     Text format     Abstract available


    January 2018
  7. EL KASSAS M, Omran D, Elsaeed K, Alboraie M, et al
    Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
    J Interferon Cytokine Res. 2018 Jan 22. doi: 10.1089/jir.2017.0121.
    PubMed     Text format     Abstract available


  8. ALEZZI ZMM, Abd El Rehim AY, Fathallah WF, Alamrani MA, et al
    Factors Affecting the Virological Response Among Chronic Hepatitis C Virus Patients in Yemen.
    J Interferon Cytokine Res. 2018;38:38-44.
    PubMed     Text format     Abstract available


    November 2017
  9. ALTRAIF IH, Sanai F, Babatin MA, Alalwan AA, et al
    Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
    J Interferon Cytokine Res. 2017;37:488-493.
    PubMed     Text format     Abstract available


    July 2017
  10. JI F, Zhou R, Wang W, Bai D, et al
    High Post-treatment alpha-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.
    J Interferon Cytokine Res. 2017 Jul 21. doi: 10.1089/jir.2017.0040.
    PubMed     Text format     Abstract available


  11. BHUSHAN A, Ghosh S, Bhattacharjee S, Chinnaswamy S, et al
    Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-alpha-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    J Interferon Cytokine Res. 2017 Jul 20. doi: 10.1089/jir.2017.0002.
    PubMed     Text format     Abstract available


    June 2017
  12. EL-MESERY M, El-Mowafy M, Elgaml A, Youssef LF, et al
    Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    J Interferon Cytokine Res. 2017 Jun 13. doi: 10.1089/jir.2016.0128.
    PubMed     Text format     Abstract available


    May 2017
  13. SALUM GM, Bader El Din NG, Ibrahim MK, Anany MM, et al
    Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker.
    J Interferon Cytokine Res. 2017 May 4. doi: 10.1089/jir.2016.0127.
    PubMed     Text format     Abstract available


    April 2017
  14. BENITO JM, Garcia-Samaniego J, Garcia M, Madejon A, et al
    Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2017 Apr 25. doi: 10.1089/jir.2016.0078.
    PubMed     Text format     Abstract available


  15. HSIAO JL, Ko WS, Shih CJ, Chiou YL, et al
    The Changed Proportion of CD45RA+/CD45RO+ T Cells in Chronic Hepatitis C Patients During Pegylated Interferon-alpha with Ribavirin Therapy.
    J Interferon Cytokine Res. 2017 Apr 17. doi: 10.1089/jir.2016.0113.
    PubMed     Text format     Abstract available


  16. SHENEEF A, Esmat MM, Mohammad AN, Mahmoud AA, et al
    Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    J Interferon Cytokine Res. 2017;37:175-180.
    PubMed     Text format     Abstract available


    March 2017
  17. NELSON M, Rubio R, Lazzarin A, Romanova S, et al
    Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
    J Interferon Cytokine Res. 2017;37:103-111.
    PubMed     Text format     Abstract available


    February 2017
  18. FOUAD R, Zachariah K, Khairy M, Khorshied M, et al
    Single Nucleotide rs760370 Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon-Riba
    J Interferon Cytokine Res. 2017;37:90-96.
    PubMed     Text format     Abstract available


    January 2017
  19. BESHEER T, El-Bendary M, Elalfy H, Abd El-Maksoud M, et al
    Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.
    J Interferon Cytokine Res. 2017 Jan 9. doi: 10.1089/jir.2016.0111.
    PubMed     Text format     Abstract available


    November 2016
  20. YI RT, Niu YH, Liu HL, Zhang TY, et al
    Natural Killer Group 2A Expressed on Both Peripheral CD3-CD56+NK Cells and CD3+CD8+T Cells Plays a Pivotal Negative Regulatory Role in the Progression of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  21. AFIFY M, Hamza AH, Alomari RA
    Correlation Between Serum Cytokines, Interferons, and Liver Functions in Hepatitis C Virus Patients.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  22. IBRAHIM MK, Salama H, Abd El Rahman M, Dawood RM, et al
    Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  23. ZWIRTES R, Narasimhan P, Wind-Rotolo MM, Xu D, et al
    Mechanisms of Hyperbilirubinemia During Peginterferon Lambda-1a Therapy for Chronic Hepatitis C Infection: A Retrospective Investigation.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  24. MOGAHED EA, Abdelaziz H, Helmy H, Ghita H, et al
    Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  25. VAN RIJNSOEVER M, Galhenage S, Mollison L, Gummer J, et al
    Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis C.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  26. HAMZA I, Eid Y, El-Sayed M, Marzaban R, et al
    Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  27. FLISIAK R, Kawazoe S, Znoyko O, Assy N, et al
    Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  28. MIUMA S, Ichikawa T, Miyaaki H, Haraguchi M, et al
    Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation.
    J Interferon Cytokine Res. 2016;36:358-66.
    PubMed     Text format     Abstract available


    March 2016
  29. ESMAT GE, Al Akel W, Abdel Aziz RA, Al Sayed Taha A, et al
    Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
    J Interferon Cytokine Res. 2016;36:149-58.
    PubMed     Text format     Abstract available


    February 2016
  30. EL RAZIKY M, Fathalah WF, Zakaria Z, Gamal Eldeen H, et al
    Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


  31. LIU X, Shen Z, Zhang H, Liang J, et al
    Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    J Interferon Cytokine Res. 2016.
    PubMed     Text format     Abstract available


    December 2015
  32. VEILLON P, Fouchard-Hubert I, Larrey D, Dao MT, et al
    Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?
    J Interferon Cytokine Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  33. ZHAO PW, Shi X, Li C, Ayana DA, et al
    IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.
    J Interferon Cytokine Res. 2015;35:454-63.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: